Decoy Therapeutics's total assets for Q2 2026 were $9.00M, an increase of 6.86% from the previous quarter. DE:FP11 total liabilities were $4.68M for the fiscal quarter, a 2.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.